Lilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 16 · Tue 29 Sep 

Companies

Otsuka

Otsuka Pharmaceutical Co., Ltd.

HQ
JP
Status
active
Listing
Listed · 4578.T
Founded
1964
Current stage
commercial

otsuka.co.jpregistryverified 2026-09-23

Notes on the record

Acquirer in D005-otsuka-transcend-2026. Added 2026-09-23 so Issue 15 can carry the OTSUKA tag. Listed parent is Otsuka Holdings Co., Ltd. (TSE 4578); ticker recorded here is the parent. Statutory disclosure runs through TDnet and EDINET, NOT the SEC, and neither has been read, which is why D005 stays confidence=reported.

Assets

No asset in data/assets.csv names this company as owner.

Registered trials

No row in data/trials.csv resolves to this company's assets.

Deals

This company is not a party to any row in data/deals.csv.

In the briefing

1 issue tagged OTSUKA.